Market Research Blog – Page 190 – New Product Development

Suture Needle Market to Reach USD 1,008.3 Million by 2034 at a 4.9% of CAGR, Amid Rising Focus on Patient Safety

The global suture needle market is poised for steady growth, with sales projected to rise from USD 625 million in 2024 to USD 1.008 billion by 2034, reflecting a CAGR of 4.9% over the forecast period. This expansion is driven by heightened awareness of patient safety, advancements in infection control, and the growing volume of surgical procedures worldwide.

Request a Sample Report Now to get Premium Insights: – https://www.futuremarketinsights.com/report-sample#5245502d47422d3134373637

Key Growth Drivers: Focus on Safety & Infection Control

Several factors are contributing to the increasing demand for suture needles, including:

Enhanced Patient Safety Standards – With hospitals and healthcare institutions emphasizing infection prevention, the demand for high-quality, sterile suture needles is rising.
Growth in Surgical Procedures – The expansion of surgical treatments, from general surgeries to specialized procedures like cardiovascular and orthopedic interventions, is fueling market demand.
Technological Innovations – Advancements in needle materials, coatings, and designs are improving wound healing and reducing complications, influencing purchasing decisions.
Expanding Healthcare Infrastructure – Emerging markets are investing heavily in hospital facilities and medical supplies, contributing to sustained market growth.

Shifting Market Dynamics and Future Outlook

As healthcare institutions prioritize minimally invasive techniques and precision-based surgical tools, manufacturers are focusing on developing needles that reduce trauma, improve healing, and enhance surgical outcomes. The increasing demand for biodegradable and antimicrobial-coated suture needles is also shaping industry trends.

Key Takeaways:

Market Growth: The suture needle market is set to surpass USD 1 billion by 2034, growing at a 4.9% CAGR.
Safety and Infection Control: Increased focus on wound care, infection prevention, and surgical efficiency is driving demand.
Rising Surgical Volume: A growing number of medical procedures, from minor outpatient treatments to major surgeries, fuels market expansion.
Innovation and Material Advancements: The shift toward biodegradable, antimicrobial, and precision-engineered needles is redefining product development.

Market Dynamics

The market is expected to exhibit a year-over-year growth rate of 5.9% in 2024, indicating strong ongoing demand.
The increasing incidence of chronic diseases necessitates more surgical interventions, which directly impacts the suture needle market.

Key Players of Suture Needles Market

Medtronic
Futura Surgicare Pvt. Ltd.
Johnson & Johnson Medical N.V.
Aurolab
Natsume Seisakusho Co. Ltd.
Alfresa Pharma Corporation
Bear Medic Corporation
SUTUREX & RENODEX
Teleflex Incorporated
Smith & Nephew
Hu-Friedy Mfg. Co. LLC
FSSB Chirurgische Nadlen GmbH
Burtons Medical Equipment Ltd.
Advin Health Care

Key Segments of Suture Needles Market

By Shape:

In terms of shape, the industry is divided into half curved, compound cure shaped needles, straight shaped needles and j shaped needles.

By Type:

In terms of type, the industry is segregated into blunt point needle, tapercut needle, reverse cutting needle, round bodied needle, conventional cutting needle and spatula needle

By Application:

In terms of application, the industry is segregated into cardiovascular, general surgery, orhopedic procedures, gynecological procedures, veterinary procedures and other applications.

By Region:

Key countries of North America, Latin America, Western Europe, Eastern, South Asia, East Asia and Middle East and Africa (MEA) have been covered in the report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Real World Evidence (RWE) Solutions Market to Reach USD 110 Billion by 2032 at a 10% of CAGR, Driven by R&D Investments and Regulatory Support

The global Real World Evidence (RWE) Solutions market is set for significant growth, expanding from USD 39.2 billion in 2021 to an estimated USD 110 billion by 2032, at a 10% CAGR. This marks a notable increase from its historical CAGR of 8.6%, highlighting the rising importance of data-driven insights in healthcare decision-making. The market is expected to generate an absolute dollar opportunity of USD 67.2 billion over the forecast period.

Request a Sample Copy Now : – https://www.futuremarketinsights.com/report-sample#5245502d47422d3134373635

Key Growth Drivers: R&D Investments and Regulatory Support

Several factors are accelerating the expansion of the RWE Solutions market, including:

Shift from Volume-Based to Value-Based Care – Healthcare providers are increasingly prioritizing outcomes over service volume, driving demand for real-world data (RWD) insights.
Favorable Government Policies – Regulatory bodies are actively encouraging RWE adoption, facilitating drug approvals and post-market surveillance.
Increased R&D Expenditure – Pharmaceutical companies are leveraging RWE solutions to enhance clinical research, optimize treatment pathways, and drive personalized healthcare initiatives.
Growing Chronic Disease Burden – The rising prevalence of chronic illnesses and an aging population are increasing the need for real-world data in long-term patient care management.

U.S. Market Leading Growth with a 3% Share

The United States holds a dominant 3% share of the global market and is anticipated to grow at a CAGR of 11.2% through 2032. The U.S. market benefits from robust regulatory support, advanced healthcare infrastructure, and major investments in AI-driven RWE analytics.

Key Takeaways:

Market Expansion: The RWE Solutions market will reach USD 110 billion by 2032, growing at a 10% CAGR.
Regulatory and R&D Push: Increasing regulatory backing and higher R&D spending are key growth accelerators.
Personalized Healthcare Focus: The shift toward tailored treatment strategies is driving the adoption of real-world evidence solutions.
U.S. Market Leadership: The U.S. accounts for a 3% share and is set to expand at 11.2% CAGR.

As the healthcare industry evolves, RWE solutions will continue to play a critical role in drug development, regulatory approvals, and precision medicine.

Market Opportunities

The projected absolute dollar opportunity of USD 67.2 billion during the forecast period presents significant opportunities for existing players and new entrants in the market.
Companies that invest in comprehensive end-to-end RWE services are well-positioned to capitalize on the growing demand for these solutions.

Key Companies Profiled

Cegedim Health Data; IBM; Icon Plc.; IQVIA; Medpace; Oracle; Parexel International Corp.; PerkinElmer, Inc.; PPD, Inc.; Syneos Health

Market Segments Covered in Real World Evidence Solutions Market Analysis

By Component:

Services
Data Sets
- Clinical Settings Data
- Claims Data
- Pharmacy data
- Patient-powered Data

By Application:

Reimbursement/Coverage & Regulatory Decision Making
Drug Development & Approvals
Medical Device Development & Approvals
Post Market Safety & Adverse Events Monitoring

By End-user:

Healthcare payers
Pharmaceutical & Medical Device Companies
Healthcare Providers
Other End-users

By Region:

North America
- USA
- Canada
Latin America
- Brazil
- Mexico
- Others
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Others
APAC
- India
- China
- Japan
- South Korea
- Australia
- Others
MEA
- South Africa
- Saudi Arabia
- UAE
- Israel
- Others

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hospital Bedsheet & Pillow Market to Reach USD 13,477.1 Million by 2034 at a 5.9% of CAGR, Driven by Hygiene and Patient Comfort Needs

The global hospital bedsheet & pillow market is projected to expand significantly, growing from USD 7,596.9 million in 2024 to USD 13,477.1 million by 2034, at a 5.9% compound annual growth rate (CAGR) over the forecast period. This steady growth highlights the increasing demand for high-quality medical bedding to enhance patient comfort, safety, and hygiene in healthcare settings.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 𝐭𝐨 𝐠𝐞𝐭 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: https://www.futuremarketinsights.com/report-sample#5245502d47422d3134373737

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: 𝐇𝐲𝐠𝐢𝐞𝐧𝐞 𝐚𝐧𝐝 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐒𝐚𝐟𝐞𝐭𝐲

Hospital bedsheets and pillow covers are essential for maintaining hygiene standards in medical facilities. These products play a crucial role in preventing infections, reducing allergens, and minimizing the risk of bedsores and skin shears for patients. The rising emphasis on infection control in hospitals and clinics, particularly in response to healthcare-associated infections (HAIs), is driving the market’s steady expansion.

𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐞𝐝 𝐃𝐞𝐦𝐚𝐧𝐝 𝐃𝐮𝐞 𝐭𝐨 𝐅𝐫𝐞𝐪𝐮𝐞𝐧𝐭 𝐔𝐬𝐞 𝐚𝐧𝐝 𝐑𝐞𝐩𝐥𝐚𝐜𝐞𝐦𝐞𝐧𝐭

Due to their frequent use and need for regular replacement, hospital bedsheets and pillow covers remain a recurring purchase for healthcare facilities. The growing number of hospital admissions, surgical procedures, and long-term care patients further fuels demand. Additionally, the increasing adoption of antimicrobial and fluid-resistant fabric technologies is boosting sales, as healthcare providers prioritize products that enhance patient protection and hospital efficiency.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

Market Growth: The hospital bedsheet & pillow market is set to grow from USD 7,596.9 million in 2024 to USD 13,477.1 million by 2034, at a 5.9% CAGR.
Hygiene & Safety Focus: Demand is rising due to infection control measures, patient safety concerns, and the need for antimicrobial fabrics.
Frequent Replacement Drives Demand: High hospital admissions and the repetitive use of bedding in medical settings sustain market expansion.

As healthcare facilities continue to prioritize cleanliness and patient well-being, the hospital bedsheet & pillow market is set for consistent growth, with innovations in fabric durability and infection-resistant materials shaping the industry’s future.

𝐊𝐞𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

Comfort and Protection: Hospital bedsheets are essential for providing comfort and protection to patients, helping to prevent bedsores and skin shears. Pillow covers, made from soft, easily washable materials, also contribute to patient comfort and hygiene.
Hygiene Maintenance: The use of high-quality linens plays a crucial role in maintaining cleanliness and preventing infections in healthcare settings. This is particularly important for patients with wounds or those who have undergone surgery.
Market Growth Drivers:
- Rising Healthcare Expenditure: Increased funding for hospitals to maintain patient comfort and hygiene is driving demand for hospital linens.
- Focus on Infection Control: There is a growing emphasis on infection prevention in healthcare facilities, leading to higher demand for sterilizable linens.
- Increasing Patient Admissions: A rise in patient admissions due to various diseases and surgeries necessitates a continuous supply of clean linens.
Customization Trends: There is a growing trend towards customized hospital bedsheets and pillow covers that enhance patient comfort and support infection control measures.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

The market is expected to exhibit a year-over-year growth of 5.9% in 2024, reflecting ongoing trends in healthcare that prioritize hygiene and patient comfort.
The increasing number of healthcare facilities and the focus on improving patient experiences are further augmenting market growth.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐨𝐟 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐁𝐞𝐝𝐬𝐡𝐞𝐞𝐭 & 𝐏𝐢𝐥𝐥𝐨𝐰 𝐂𝐨𝐯𝐞𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

Unitex Textile Rental Services Inc.
Emes Textiles Pvt. Ltd.
Tetsudo Linen Service Co. Ltd.
ImageFIRST Healthcare Laundry Specialists
Healthcare Services Group Inc.
Emerald Textiles
Celtic Linen
Raenco Mills
Elizabethtown Laundry Company
V-linen Pvt. Ltd.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐁𝐞𝐝𝐬𝐡𝐞𝐞𝐭 & 𝐏𝐢𝐥𝐥𝐨𝐰 𝐂𝐨𝐯𝐞𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

By Type:

In terms of Type, the industry is divided into bedsheet, and pillow cover.

By Product Type:

In terms of product type, the industry is segregated into disposable and reusable.

By Region:

Key countries of North America, Latin America, Europe, East Asia, South Asia, Middle East and Africa (MEA), and Oceania have been covered in the report.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Micro Computed Tomography Market to Reach USD 721.8 Million by 2034 at a 10.8% of CAGR, Driven by Non-Destructive Testing Demand

The global micro computed tomography (micro-CT) market is set for substantial expansion, with its valuation projected to grow from $258.8 million in 2024 to $721.8 million by 2034, reflecting a 10.8% compound annual growth rate (CAGR) over the forecast period. This growth trajectory highlights the increasing adoption of micro-CT imaging across various industries, particularly for non-destructive testing (NDT) applications.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰: – https://www.futuremarketinsights.com/report-sample#5245502d47422d3134373733

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫: 𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐍𝐨𝐧-𝐃𝐞𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐯𝐞 𝐓𝐞𝐬𝐭𝐢𝐧𝐠

A primary factor driving market expansion is the rising demand for non-destructive testing methods across multiple industries. Sectors such as aerospace, automotive, and manufacturing are increasingly adopting micro-CT technology due to its ability to provide detailed internal imaging of components without causing any damage to the sample. This capability is particularly valuable for quality control, failure analysis, and material characterization, enabling companies to enhance product reliability and performance.

𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐝𝐨𝐩𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬

Advancements in micro-CT technology, including higher resolution imaging, faster scanning speeds, and automated data analysis, are further boosting adoption. The growing use of micro-CT in medical research, biotechnology, and materials science is also contributing to market growth. As imaging techniques become more precise and efficient, industries are leveraging micro-CT solutions to improve product development, testing, and innovation.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

Market Growth: The micro-CT market is expected to rise from USD 258.8 million in 2024 to USD 721.8 million by 2034, at a 10.8% CAGR.
Non-Destructive Testing Demand: Industries such as aerospace, automotive, and manufacturing are driving adoption due to micro-CT’s ability to analyze internal structures without damage.
Technological Advancements: Improvements in resolution, scanning speed, and automation are enhancing market penetration across various industries.

With increasing industrial applications and ongoing technological innovations, the micro-CT market is poised for significant expansion, shaping the future of advanced imaging and quality assurance.

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐆𝐫𝐨𝐰𝐭𝐡

Increasing Demand for Non-Destructive Testing Methods:
- A significant driver in the micro-CT sector is the rising demand for non-destructive testing (NDT) methods across various industries such as aerospace, automotive, and manufacturing. Micro-CT provides detailed internal imaging without damaging the sample, making it an invaluable tool for quality control and failure analysis.
Advancements in Imaging Technology:
- Continuous improvements in micro-CT technology, including higher resolution imaging and faster scanning times, are enhancing the capabilities of these systems. This allows for more detailed visualizations of internal structures, facilitating better diagnosis and analysis.
Growing Applications in Research and Clinical Settings:
- The expanding use of micro-CT systems in preclinical testing, material science, and life sciences research is driving market growth. These applications benefit from the high-resolution imaging capabilities that micro-CT offers.
Rising Healthcare Expenditure:
- Increased investment in healthcare infrastructure and research is fueling demand for advanced imaging technologies like micro-CT. As healthcare providers seek to improve diagnostic capabilities, the adoption of micro-CT systems is expected to rise.
Focus on Quality Control and Product Development:
- Industries are increasingly relying on advanced imaging techniques for quality control processes and product development. The ability to assess structural integrity without compromising samples is crucial for maintaining performance standards.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

Technological Innovations: The market is witnessing a trend towards more compact and user-friendly micro-CT devices that enhance operational efficiency and user experience.
Emerging Markets: Growth in emerging markets is contributing to increased demand for micro-CT systems as these regions expand their healthcare and manufacturing capabilities.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

Bruker Corporation
PerkinElmer
Thermo Fisher Scientific
Zeiss
NeoScan
Sanying Precision Instruments Co.Ltd
North Star Imaging Inc
SCANCO Medical AG
TESCAN

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐌𝐢𝐜𝐫𝐨 𝐂𝐨𝐦𝐩𝐮𝐭𝐞𝐝 𝐓𝐨𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

By Product Type:

By product type, the industry is divided into in-vivo and ex-vivo.

By Application:

By application, the industry is divided into life sciences, orthopedics, dentistry, agribio, material science and geology/oil and gas geology

By Region:

Key countries of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe and Middle East & Africa have been covered in the report.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Fructosamine Test Industry Valuation to Total USD 399.9 Million by 2034 at a CAGR of 3.8% amid Rising Prevalence of Diabetes | FMI

The global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total market valuation is expected to increase from USD 275.9 million in 2024 to USD 399.9 million by 2034.

Several factors are anticipated to drive the growth of the fructosamine test industry over the assessment period. These include increasing incidence of diabetes and obesity, growing awareness about fructosamine testing, and rising need for efficient blood glucose monitoring diagnostic tests.

Fructosamine testing has become a widely used method for measuring blood glucose. It does not require fasting and can be helpful when an HbA1c test is unreliable.

Explore Market Dynamics: Request Your Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d37303330

There has been a sharp rise in cases of diabetes during the last few years. For instance, according to the International Diabetes Federation, around 537 million adults were living with diabetes in 2021. This, in turn, is expected to uplift demand for fructose tests.

Fructosamine testing is an important method that helps medical professionals monitor glycemic management in diabetics. The growing demand for these monitoring technologies highlights the need to address the expanding diabetes epidemic. It also shows the critical role innovative approaches, such as fructosamine testing, play in treating and reducing the effects of this chronic condition.

Another notable trend is the growing focus on fructosamine point-of-care diagnostics, which provide quick and easy glycemic control monitoring at the patient’s location. This change speeds up the evaluation of fast-acting blood glucose levels, allowing for rapid medical choices.

Point-of-care testing minimizes the need for a large laboratory infrastructure by streamlining the diagnostic procedure and providing instant results. This trend supports proactive diabetes management by improving patient accessibility to timely healthcare information, which is the primary goal.

Point-of-care fructosamine tests are a major improvement in decentralized healthcare due to their accessibility and speed. They significantly promote quicker interventions and improve overall patient outcomes.

Key Takeaways from the Market Study:

The global market for fructosamine test is set to attain a valuation of USD 399.9 million in 2034
By disease indication, the diabetes II segment held a market share of about 59.4% in 2023.
By sample, the blood serum is expected to progress with a CAGR of 3.5%.
By end-user, the hospitals segment accounted for a revenue share of 29.8% in 2023.
North America dominates the global market with a share of around 31.5%.
The United States market value totaled USD 74.7 million in 2023.
Demand in India is predicted to rise at 7.9% CAGR through 2034.

“The rising focus on personalized diabetes management and compliance with CLIA standards enhances the use of fructosamine tests in clinical laboratories. This, in turn, will boost the growth of the fructosamine test industry over the forecast period,” says an analyst of Future Market Insights (FMI).

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report! https://www.futuremarketinsights.com/reports/fructosamine-test-market

Who is Winning?

The primary strategies employed by the industry’s leading manufacturers include new product launches, distribution agreements, partnerships, acquisitions, and collaborations. Several companies are also launching awareness programs and campaigns to expand their customer base.

For instance,

In June 2023, Fortress Diagnostics created awareness with a focus on men’s health testing awareness month and posted an article on diabetes and a higher risk of diabetes due to reduced rates of weight gain and accumulation of fat.

Key Companies Profiled:

Beckman Coulter, Inc.; Randox Laboratories Ltd.; Fortress Diagnostics; KAMIYA BIOMEDICAL COMPANY; Abbexa; Weldon Biotech, Inc.; Eurolyser Diagnostica GmbH; F. Hoffmann-La Roche Ltd; Asahi Kasei Pharma Corporation (EKF DIAGNOSTICS); LifeSpan BioSciences, Inc; Zhejiang Kangte Biotechnology Co., Ltd.; Diazyme; Abcam plc.; Weldon Biotech, Inc.; Bio Vision; Mybiosource

Fructosamine Test Market Outlook by Category:

By Disease Indication:

Diabetes I
Diabetes II
Gestational Diabetes

By Sample:

Blood Serum
Blood Plasma

By Application:

Clinical Diagnostics for Human
Clinical Diagnostics for Animals
Research Use

By End-user:

Hospitals
Specialty Clinics
Veterinary Hospitals
Diagnostic Laboratories
Academic & Research Institutes

By Region:

North America
Latin America
East Asia
South Asia & Pacific
Western Europe
Eastern Europe
Middle East & Africa

Start Making Data-Driven Decisions – Request a Market Analysis! https://www.futuremarketinsights.com/industry-analysis/in-vitro-diagnostics-devices

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Set for Robust Growth Reaching USD 11,698.1 Million by 2034 at a CAGR of 4.4%

Future Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the impressive growth trajectory of the global advanced therapeutics pharmaceutical outsourcing industry. According to the report, the market, valued at USD 7,592.8 million in 2024, is projected to experience a robust expansion, reaching an estimated USD 11,698.1 million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 4.4%.

Advanced therapeutics represent a groundbreaking sector within the pharmaceutical industry, encompassing innovative treatments such as gene therapies, cell therapies, mRNA-based therapies, and other cutting-edge personalized and precision medicine approaches. These advanced therapies are poised to address significant unmet medical needs and transform treatment paradigms across a wide array of disease areas.

Unlock Key Market Trends: Get Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d3138373535

Recognizing the complexity and rapid evolution of advanced therapeutics, pharmaceutical companies are increasingly turning to external partners for collaboration. Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) play a pivotal role in this ecosystem, offering specialized expertise, infrastructure, and capabilities to support the development and commercialization of advanced therapies.

The projected growth of the advanced therapeutics pharmaceutical outsourcing market underscores the increasing demand for outsourced services to support the development, manufacturing, and commercialization of advanced therapies. With advancements in biotechnology and an expanding pipeline of novel therapeutic modalities, the market is expected to witness sustained growth opportunities in the coming years.

Key Takeaways from the Market Study:

By service type, contract development and manufacturing organizations (CDMOs) are expected to surge at a CAGR of surge at a CAGR of 3.7% by 2034.
By indication, oncology held a 46.1% market value share in 2023.
By therapy, gene therapy held the leading share in the market of 49.6% in 2023.
By phases, commercial manufacturing, and packaging segment dominates with the leading share, accounting for 54.9% in 2023.
North America is the primary region, holding a substantial value share of 37.3% in 2023.

“Development and manufacturing of advanced therapeutics, such as gene and cell therapies, is responsible for the growth of the advanced therapeutics pharmaceutical outsourcing market worldwide,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends! https://www.futuremarketinsights.com/reports/advanced-therapeutics-pharmaceutical-outsourcing-market

Competitive Landscape:

The advanced therapeutics pharmaceutical outsourcing industry encourages collaborative innovation, with pharmaceutical companies and outsourcing partners working together to advance technologies, overcome challenges, and bring novel therapies to market.

For instance,

In June 2023, KD Pharma Group and DUDE CHEM announced their strategic partnership to usher in a new era of digital innovation, greatly enhancing the efficiency and safety of pharmaceutical drug and therapy development.
In January 2021, Thermo Fisher Scientific, Inc. acquired the viral vector business from Henogen S.A (Groupe Novasep SAS).

Key Companies Profiled:

Croda International Plc
Charles River Laboratories International, Inc.
Catalent, Inc.
QuintilesIMS (IQVIA)
Parexel International Corporation
ICON plc
PPD, Inc. (Thermo Fisher Scientific)
LabCorp (Laboratory Corporation of America Holdings)
Syneos Health
WuXi AppTec
Lonza Group
Piramal Pharma Solutions
SGS SA
Evotec SE
CMC Biologics (Now AGC Biologics)
Marken (A UPS Company)
Cytovance Biologics
Samsung Biologics
CordenPharma
Recipharm AB
Vetter Pharma International GmbH
Cryoport Systems, Inc.
ProPharma Group
Fujifilm Diosynth Biotechnologies
Medpace
Novotech Pty Ltd.
Axcella Health Inc.
CelerionAshland

Stay Informed Access Our Comprehensive Healthcare Market Research! https://www.futuremarketinsights.com/industry-analysis/healthcare-services

Advanced Therapeutics Pharmaceutical Outsourcing Industry Segmentation:

By Service Type:

Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)

By Indication:

Oncology
Neurology
Cardiology
Infectious Diseases
Others

By Therapy:

Cell Therapy
Gene Therapy
RNA-based Therapies
Others

By Phases:

Preclinical Services
Clinical Services
Commercial Manufacturing and Packaging

By Region:

North America
Latin America
East Asia
South Asia and Pacific
Western Europe
Eastern Europe
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Global Peripherally Inserted Central Catheter Industry Poised for Steady Growth USD 1,289.9 Million by 2034 at a CAGR of 2.2% Amid Rising Cancer Cases | FMI

The global peripherally inserted central catheter industry value is predicted to grow from USD 1,037.0 million in 2024 to USD 1,289.9 million in 2034. Overall demand for PICCs will likely increase at 2.2% CAGR throughout the assessment period.

Peripherally inserted central catheters (PICCs) are in greater demand due to the rising prevalence of cancer. This is because chemotherapy medications are injected directly into the veins using PICCs, preventing vein discomfort.

The need for peripherally inserted central catheters is also expected to rise in response to the growing need for parental nourishment in people with illnesses or ailments affecting food intake and nutritional digestion. Further, the market is anticipated to expand globally due to the continuous approval of PICC products.

Gain Access to Market Trends: Request Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d3132373236

Programs that raise awareness of cancer aim to reduce the stigma and fear related to cancer treatment. This could indirectly encourage the use of PICC lines and other medical interventions in general, increasing their acceptance of longer-term intravenous therapies.

Increasing cancer awareness campaigns and the development of tunneled PICC products have facilitated market growth and are anticipated to drive its expansion in the future. However, the peripherally inserted central catheter industry is expected to face challenges due to several variables, including a rise in deep vein thrombosis and a high risk of bloodstream infections.

Key Takeaways from the Market Study:

The global PICC market is projected to total USD 1,289.9 million in 2034.
By product, power injected PICC segment is expected to display a CAGR of 2.2% over the forecast period.
By lumen, double lumen segment is expected to show a CAGR growth of 3.0% over the forecast period.
By application, the long-term IV infusion segment is projected to surge at a CAGR of 0.8% by 2034.
North America is anticipated to witness a CAGR of 1.2% through 2034.
The United States market value is set to total USD 545.82 million by the end of 2034.

“Rising focus on combating hospital-acquired infections and growing geriatric worldwide are expected to boost the peripherally inserted central catheter market over the forecast period,”- says a lead analyst of Future Market Insights (FMI).

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report! https://www.futuremarketinsights.com/reports/peripherally-inserted-central-catheters-market

Who is Winning?

Key PICC manufacturers are concentrating on introducing novel solutions with enhanced features, including antimicrobial coatings. They also employ strategies like facility expansions, mergers, agreements, collaborations, and acquisitions to boost their revenue and expand their footprint.

Recent developments:

In June 2023, Cardinal Health announced that it would build a new distribution center in Greenville, South Carolina. The new distribution hub will give medical supply providers to Americans with critical and chronic health conditions.
In May 2023, Teleflex Incorporated launched two new devices, Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet, designed explicitly for PICC insertion procedures.

Key Companies Profiled:

Vygon (UK) Ltd; Becton, Dickinson and Company; Cardinal Health, Inc.; ICU Medical, Inc.; Kimal Plc; Polymedicure; Teleflex Incorporated; AngioDynamics; B. Braun Medical Ltd; Haolang Technology (Foshan) Limited Co., Ltd.; Medical Components, Inc; Argon Medical; Access Vascular, Inc.; Utah Medical Products, Inc.; Biowy Corporation; Medi-Tech Devices; Footprint Medical Incorporated; PFM Medical, Inc.; HuskMedical; NeoMedical; Cook Medical

Get Your Free Healthcare Market Growth Projections Today! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

Peripherally Inserted Central Catheter (PICC) Market by Category:

By Product:

Conventional PICC
Power Injected PICC
Neonatal PICC

By Lumen:

Single Lumen
Double Lumen
Multiple Lumen

By Application:

Chemotherapy
Long-term IV Infusion
Parenteral Nutrition
Blood Transfusion
Difficult Intravenous Access
Others

By End User:

Hospitals
Cancer Research Institutes
Long Term Care Centers
Independent Infusion Centers
Ambulatory Surgical Center
Home Care Settings

By Region:

North America
Latin America
East Asia
South Asia & Pacific
Western Europe
Eastern Europe
Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Global Aortic Endograft Industry Valuation to Reach USD 5,513.5 million by 2034 exhibit a CAGR of 4.9% Amid Rising Prevalence of Aortic Aneurysms | FMI

The global aortic endograft industry was valued at around USD 3,255.5 million in 2023 and is anticipated to exhibit a CAGR of 4.9% over the forecast period. Accordingly, total market revenue is set to grow from USD 3,430.3 million in 2024 to USD 5,513.5 million by 2034.

Several factors are expected to drive growth of the aortic endograft industry during the assessment period. These include growing incidence of aortic aneurysms and increasing popularity of minimally invasive procedures.

The surge in the incidence rate of lifestyle diseases is a key driving force behind the growth of the aortic endograft market. Similarly, the increasing geriatric population will likely uplift aortic endograft demand.

Track the Latest Market Developments: Request a Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d3138373336

Lifestyle diseases, including hypertension, atherosclerosis, and diabetes, contribute to the development of aortic pathologies such as abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA). This demographic shift, characterized by a rising prevalence of risk factors and an aging population, has created a substantial demand for advanced medical interventions, particularly aortic endografts.

Lifestyle diseases such as hypertension and atherosclerosis significantly increase the risk of aortic diseases. Persistent high blood pressure and the buildup of fatty deposits in the arteries contribute to the weakening and dilation of the aorta, leading to an increased incidence of aneurysms.

Diabetes, another lifestyle-related condition, is known to accelerate the progression of atherosclerosis and increase the risk of cardiovascular complications, including aortic diseases. The prevalence of diabetes is on the rise globally, further contributing to the burden of aortic pathologies.

The risk of developing aortic pathologies, including aneurysms, rises substantially with age. The natural aging process leads to changes in the structure and elasticity of the aorta, making it more susceptible to dilation and aneurysm formation.

The combination of a growing incidence of lifestyle diseases and an aging population suggests a sustained demand for aortic endografts in the future. As individuals live longer, the prevalence of aortic pathologies is likely to increase, necessitating advanced treatment options to address the specific needs of the elderly population.

Ongoing technological advancements significantly impact the aortic endograft industry. Innovations such as advanced materials, 3D printing, and robotic-assisted procedures enhance the safety and efficacy of aortic endograft interventions.

The continuous evolution of technology is expected to introduce more sophisticated and patient-specific solutions. These advancements can lead to improved outcomes, reduced complications, and expanded applications for aortic endografts.

Key Takeaways from the Market Study

The global market for aortic endografts is set to total USD 5,513.5 million by 2034.
By product, the abdominal aortic grafts segment is estimated to hold a value share of 8% in 2024.
By material, polymeric endografts segment is poised to grow at a CAGR of 3% through 2034.
By procedure, the endovascular aneurysm repair (EVAR) segment is set to expand at 5% CAGR between 2024 and 2034.
The United States aortic endograft market value is set to total USD 1,231.9 million in 2033.
Demand in India is projected to grow at a CAGR of 6% through 2034.

“Growing prevalence of aneurysms and rising geriatric population are key factors responsible for fueling growth of the aortic endograft market,” says an analyst of Future Market Insights (FMI).

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends! https://www.futuremarketinsights.com/reports/aortic-endograft-market

Market Competition

Increasing new product launches and FDA approvals is the key strategy of leading manufacturers like Terumo Corporation and Braile Biomedica, among others, to enhance their presence in the market and compete with other competitors. Following are a few examples of key developments made by them to be at the top position:

In August 2020, Terumo Corporation Aortic announced that the TREO Abdominal Aortic Stent-Graft System has been approved for sale in the United States by the Food and Drug Administration (FDA) to treat patients with abdominal aortic aneurysms (AAA).
In August 2018, Rafael Braile, the Executive Director of Braile Biomedical, showcased the company’s brands at the India Valves 2018 event, which took place in India.

Key Companies Profiled:

Medtronic; Cook; W. L. Gore & Associates, Inc.; Braile Biomédica; Cordis Corporation; Endologix LLC; Endospan; LifeTech Scientific; MicroPort Scientific Corporation; Terumo Corporation

Key Market Segments Covered in Aortic Endograft Industry Research:

By Product:

Abdominal Aortic Grafts
Thoracic Aortic Grafts

By Material:

Metallic Endografts
- Stainless Steel
- Nitinol
Polymeric Endografts
- Dacron
- ePTFE

By Procedure:

Open Surgical Repair
Endovascular Aneurysm Repair (EVAR)
- Standard EVAR
- Fenestrated EVAR
- Branched EVAR
- TEVAR
- Iliac branched EVAR
- Chimney EVAR
- Hybrid EVAR

By End User:

Hospitals
- Private Hospitals
- Public Hospitals
Ambulatory Surgical Centers

By Region:

United States
Japan
Europe
North America
Latin America
Asia Pacific Excluding Japan
Middle East & Africa

Request Your Free Healthcare Industry Analysis Today! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

About Future Market Insights (FMI)

Contact Us:

Global Testosterone Boosters Industry size is expected to reach USD 9,083.9 Million by 2034 surge at a CAGR of 6.3%

As the global testosterone booster industry continues its remarkable expansion, FMI is strategically positioned to capitalize on this dynamic opportunity. According to recent market research, the testosterone booster market is projected to achieve a significant valuation of USD 5,188.1 million by 2024, driven by a robust Compound Annual Growth Rate (CAGR) of 6.3%. This growth trajectory is set to propel the market to an impressive valuation of USD 9,083.9 million by 2034.

The escalating demand for testosterone boosters is largely attributed to the natural decline in testosterone levels associated with aging. This shift has led to a growing need for products designed to address hormonal imbalances, particularly among individuals dedicated to achieving their fitness goals. In an era characterized by fast-paced lifestyles, increased stress, sedentary habits, and suboptimal dietary choices, maintaining hormonal balance is more essential than ever. Testosterone boosters have emerged as a viable solution to counteract the negative impacts of these lifestyle factors and foster a healthier hormonal equilibrium.

Explore Market Dynamics: Request Your Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d3138373237

Moreover, the widespread adoption of testosterone supplements can be attributed in part to compelling endorsements from athletes and celebrities, as well as innovative marketing strategies. These endorsements often highlight the manifold benefits of testosterone boosters, ranging from enhanced vitality and muscle growth to improved physical performance.

In line with this burgeoning market trend, FMI is intensifying its efforts to expand its footprint in the testosterone booster industry. By leveraging our expertise and resources, we aim to raise awareness about the benefits of our products among consumers. Additionally, we are committed to educating the public about various health conditions through informative blog posts, while simultaneously promoting our brand.

As one of the key players in this dynamic market landscape, FMI remains steadfast in its mission to deliver high-quality testosterone booster products that empower individuals to optimize their health and well-being.

Key Takeaways from the Market Study:

D-aspartic acid is the leading segment as a component type and held around 28.7% market value share in 2023.
The global market is expected to surge at a CAGR of 6.3% by 2034.
Fenugreek is the leading segment as the source, holding around 26.7% market value share in 2023.
By distribution channel, online pharmacies held a 42.1% market value share in 2022.
North America is considered as the leading region, growing at a CAGR of 5.4% during the forecast period.

“Rising prevalence of chronic diseases such as HIV/AIDS, kidney ailments, as well as rise in geriatric population is leading to increasing prevalence of hypogonadism, which will propel sales of testosterone boosters across the globe,” says a lead analyst at Future Market Insights (FMI).

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report! https://www.futuremarketinsights.com/reports/testosterone-booster-market

Market Competition:

The market for testosterone boosters is fragmented, and several local, emerging, and established players exist within the market sphere. Key players are focusing on expanding into the market through several growth strategies such as marketing, mergers, new launches, investments, and partnerships.

In 2023, TestoGen introduced promotional schemes such as “free global shipping,” “bonus gift vouchers,” and “multibuy savings offers” to expand their customer base.
In 2023, Roar Ambition Ltd. implemented a unique approach to market expansion. They displayed pictures of their clients holding the company’s products on their website along with their testimonials; this provides a direct promotion of the products through their customers – to their customers.

Key Companies Profiled:

Evolution Nutrition LLC
Musclepro Nutrition Pvt. Ltd.
Roar Ambition Ltd.
Nutri Bolism
TestoRush
Optimum Nutrition
Prime Male
TEK Naturals
TestoGen
GNC
Testofuel
Healeo Nutrition
Pharmgrade
Zenith Nutrition

Access Exclusive Healthcare Industry Data and Trends! https://www.futuremarketinsights.com/industry-analysis/pharmaceuticals

Testosterone Booster Market Segmentation by Category:

By Component:

D-aspartic Acid
Vitamin D
Zinc
Magnesium
Others

By Source:

Ginseng
Ashwagandha
Fenugreek
Oyster Extract
Others

By Distribution Channel:

Hyper/Supermarket
Retail Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Global Pediatric Heart Valve Repair and Replacement Industry Poised for Remarkable Growth Reaching USD 4,490.5 Million by 2034 at a CAGR of 2.7%

The global pediatric heart valve repair and replacement industry is on a promising growth trajectory, with recent analysis projecting a substantial increase in market value. By 2024, the market is expected to reach approximately USD 3,440.6 million, and it is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 2.7%, culminating in a total market valuation of USD 4,490.5 million by 2034.

This optimistic outlook reflects the rising demand for advanced medical solutions driven by several critical factors. Chief among these is the increasing prevalence of heart defects in neonates, with congenital heart defects being a significant concern. As the number of congenital heart conditions continues to rise, the need for innovative and effective pediatric heart valve repair and replacement solutions becomes increasingly urgent.

Access Key Market Insights: Request a Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d3138363935

Congenital heart defects (CHD) represent a significant global health concern, affecting approximately 1% of annual births in the United States alone. Sadly, they stand as a leading cause of infant mortality associated with birth defects. The statistics underscore a pressing need for heightened attention and resources to effectively manage this growing challenge.

The incidence of hypertrophic cardiomyopathy, a type of CHD, is estimated at 5 per 1 million children, with a prevalence of less than 0.2% in the general population. In India, CHD’s reported prevalence ranges from 8 to 10 out of every 1,000 live births, contributing to about one-fourth of all congenital malformations and 10% of infant mortality.

The variability in prevalence across different regions and settings highlights the necessity for a comprehensive approach to address this public health issue. As the incidence of CHD continues to rise globally, it not only poses a significant health burden but also drives advancements in pediatric cardiac care, particularly in the realm of heart valve repair and replacement.

The escalating prevalence of congenital heart defects underscores the urgent need for ongoing research, technological innovation, and the development of advanced treatment modalities. The pediatric heart valve repair and replacement market, in particular, emerges as a critical arena for meeting the evolving needs of infants with complex cardiac conditions, offering hope and improved outcomes for this vulnerable patient population.

As we move forward, it is imperative for stakeholders across the healthcare spectrum to collaborate, innovate, and invest in strategies aimed at addressing the challenges posed by congenital heart defects. Together, we can pave the way for a future where every child has access to optimal cardiac care and a chance at a healthy life.

Key Takeaways from the Market Study:

The global pediatric heart valve repair and replacement industry size is set to reach USD 4,490.5 million in 2034.
Based on product, the bioprosthetic heart valves segment accounted for a value share of 5% in 2023.
By indication, the congenital heart defects segment held a market share of 9% in 2023.
By end-user, the hospital segment is forecast to expand at a 8% CAGR through 2034.
North America dominates the global market, holding a value share of 9%.
Demand in India is anticipated to rise at a 6% CAGR between 2024 and 2034.
China is set to register a CAGR of 5% through 2034.

“Increasing incidence of heart defects in newborns and requirement of necessary development to address unmet medical needs is responsible for the growth of the pediatric heart valve repair and replacement market,” says an analyst of Future Market Insights (FMI).

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report! https://www.futuremarketinsights.com/reports/pediatric-heart-valve-repair-and-replacement-market

Market Competition:

Collaborating with other companies, research institutions, or technology providers, along with strategic product launches and regulatory approvals, significantly enhances a manufacturer’s capabilities. These dynamic partnerships encompass joint ventures, licensing agreements, and collaborations aimed at developing and integrating complementary technologies into advanced and market-ready products.

Recent Development:

In 2023, Medtronic revealed the reintroduction of its Harmony transcatheter pulmonary valve system. It is a minimally invasive option for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). It provides an alternative to traditional open-heart surgery.

Key Companies Profiled:

The Charles Stark Draper Laboratory, Inc.
Medtronic
Abbott
CryoLife
Edwards Lifesciences Corporation
Venus MedTech

Harness Healthcare Market Trends for Your Advantage! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

Pediatric Heart Valve Repair and Replacement Industry Segmentation:

By Product:

Heart Valve Repair
Mechanical Heart Valves
Bioprosthetic Heart Valves
Transcatheter Aortic Valve Implantation (TAVI)

By Indication:

Congenital Heart Defects
Heart Muscle Disease
Atresia
Arrhythmias
Other Cardiac Disorders

By End-user:

Hospitals
Independent Cardiac Catheterization Labs
Ambulatory Surgical Centers

By Region:

North America
Latin America
East Asia
South Asia and Pacific
Western Europe
Eastern Europe
Middle East and Africa

About Future Market Insights (FMI)

Contact Us: